Search Grants

{
  "ok": true,
  "page": 1,
  "limit": 3,
  "total": 55,
  "total_pages": 19,
  "grants": [
    {
      "opportunity_id": 357075,
      "number": "PAR-25-081",
      "title": "National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)",
      "agency_code": "HHS-NIH11",
      "agency_name": "National Institutes of Health",
      "top_agency": "HHS",
      "category": "Discretionary",
      "category_explanation": null,
      "funding_instruments": [
        "Grant"
      ],
      "funding_categories": [
        "Education",
        "Health"
      ],
      "cfda_numbers": [
        "93.393",
        "93.394",
        "93.395",
        "93.399"
      ],
      "eligible_applicants": [
        "State governments",
        "County governments",
        "City or township governments",
        "Special district governments",
        "Independent school districts",
        "Public and State controlled institutions of higher education",
        "Native American tribal governments (Federally recognized)",
        "Public housing authorities/Indian housing authorities",
        "Native American tribal organizations (other than Federally recognized)",
        "Nonprofits with 501(c)(3) status (non-higher-education)",
        "Nonprofits without 501(c)(3) status (non-higher-education)",
        "Private institutions of higher education",
        "For-profit organizations (other than small businesses)",
        "Small businesses",
        "Others"
      ],
      "eligibility_info": "Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.",
      "post_date": "2024-11-12",
      "close_date": "2027-01-07",
      "close_date_explanation": null,
      "archive_date": "2027-02-12",
      "last_updated": "2024-11-12",
      "award_ceiling": 499999,
      "award_floor": null,
      "total_funding": 499999,
      "expected_awards": null,
      "cost_sharing": false,
      "is_forecast": false,
      "fiscal_year": null,
      "description": "Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.",
      "url": "http://grants.nih.gov/grants/guide/pa-files/PAR-25-081.html",
      "contact_email": "grantsinfo@nih.gov",
      "updated_at": "2026-09-06 05:36:19",
      "status": "posted"
    },
    {
      "opportunity_id": 360918,
      "number": "PAR-25-444",
      "title": "Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)",
      "agency_code": "HHS-NIH11",
      "agency_name": "National Institutes of Health",
      "top_agency": "HHS",
      "category": "Discretionary",
      "category_explanation": null,
      "funding_instruments": [
        "Grant"
      ],
      "funding_categories": [
        "Health"
      ],
      "cfda_numbers": [
        "93.397"
      ],
      "eligible_applicants": [
        "State governments",
        "County governments",
        "City or township governments",
        "Special district governments",
        "Independent school districts",
        "Public and State controlled institutions of higher education",
        "Native American tribal governments (Federally recognized)",
        "Native American tribal organizations (other than Federally recognized)",
        "Nonprofits with 501(c)(3) status (non-higher-education)",
        "Nonprofits without 501(c)(3) status (non-higher-education)",
        "Private institutions of higher education",
        "For-profit organizations (other than small businesses)",
        "Small businesses",
        "Others"
      ],
      "eligibility_info": "Specific to this NOFO:For New (Type 1) applications, an applicant institution must have a funding base of $10,000,000 (Clinical Cancer Centers) or $6,000,000 (Basic Cancer Centers) in annual direct costs of NIH funding that is cancer-focused, as defined by the Research Condition and Disease Categorization (RCDC) system. Please contact the NCI Office of Cancer Centers (https://cancercenters.cancer.gov/) for assistance in determining the RCDC funding base.For Renewal (Type 2) applications, an applicant institution must have a funding base of at least $10,000,000 in annual direct costs of peer-reviewed, cancer-related funding. If the Cancer Center is an approved consortium of institutions, the funding base of the Center will be the sum of the funding bases of all participating institutions. However, funding (and other data) awarded to consortium partners may be included only if the partner has been previously evaluated in CCSG peer-review and approved by NCI.Example of NCI peer-reviewed mechanisms that may be included for determining eligibility to apply for a CCSG: DP1, DP2, R00, R01, R03, R15, R18, R21, R24, R25, R33, R35, R37, R41, R42, R50, R55, R56, P01, P20, P30s other than the CCSG, P50, SC1, SC2, U01, U10, U19, U24, U54, U56, UH2, UH3, UG3, T32, K and F series awards and N01s (excluding SEER and other N01s funding materials, services, or research resources). Cancer-relevant research funded by these mechanisms from other NIH Institutes may also be counted towards the minimum, as do cancer-relevant grants and contracts from the peer-reviewed funding sources listed in: https://cancercenters.cancer.gov/sites/default/files/PeerReviewFundingOrganizations.pdfNOTE: New (Type 1) applications cannot request evaluation for comprehensiveness status.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign compo",
      "post_date": "2025-11-26",
      "close_date": "2028-09-25",
      "close_date_explanation": null,
      "archive_date": "2028-10-30",
      "last_updated": "2026-01-05",
      "award_ceiling": null,
      "award_floor": null,
      "total_funding": null,
      "expected_awards": null,
      "cost_sharing": false,
      "is_forecast": false,
      "fiscal_year": null,
      "description": "This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. CCSGs support three types of Cancer Centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Clinical Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas, and 3) Basic Cancer Centers, which focus on basic laboratory research. The purpose of all types of NCI-Designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through this NOFO are expected to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of Shared Resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.",
      "url": null,
      "contact_email": "ncicenters-r@mail.nih.gov",
      "updated_at": "2026-09-06 05:36:26",
      "status": "posted"
    },
    {
      "opportunity_id": 357030,
      "number": "PA-25-172",
      "title": "Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)",
      "agency_code": "HHS-NIH11",
      "agency_name": "National Institutes of Health",
      "top_agency": "HHS",
      "category": "Discretionary",
      "category_explanation": null,
      "funding_instruments": [
        "Grant"
      ],
      "funding_categories": [
        "Education",
        "Health"
      ],
      "cfda_numbers": [
        "93.393",
        "93.399"
      ],
      "eligible_applicants": [
        "State governments",
        "County governments",
        "City or township governments",
        "Special district governments",
        "Independent school districts",
        "Public and State controlled institutions of higher education",
        "Native American tribal governments (Federally recognized)",
        "Public housing authorities/Indian housing authorities",
        "Native American tribal organizations (other than Federally recognized)",
        "Nonprofits with 501(c)(3) status (non-higher-education)",
        "Nonprofits without 501(c)(3) status (non-higher-education)",
        "Private institutions of higher education",
        "For-profit organizations (other than small businesses)",
        "Small businesses",
        "Others"
      ],
      "eligibility_info": "Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.",
      "post_date": "2024-11-07",
      "close_date": "2028-01-07",
      "close_date_explanation": null,
      "archive_date": "2028-02-12",
      "last_updated": "2024-11-07",
      "award_ceiling": null,
      "award_floor": null,
      "total_funding": null,
      "expected_awards": null,
      "cost_sharing": false,
      "is_forecast": false,
      "fiscal_year": null,
      "description": "This Notice of Funding Opportunity (NOFO) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, healthcare delivery, and digital health and data science, and implementation science.",
      "url": "http://grants.nih.gov/grants/guide/pa-files/PA-25-172.html",
      "contact_email": "grantsinfo@nih.gov",
      "updated_at": "2026-09-06 05:36:19",
      "status": "posted"
    }
  ]
}